• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumoni

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2020 Nov 20;ciaa1747.
doi: 10.1093/cid/ciaa1747. Online ahead of print.
Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters


Anna Jinxia Zhang[SUP] 1 [/SUP], Andrew Chak-Yiu Lee[SUP] 1 [/SUP], Jasper Fuk-Woo Chan[SUP] 1 2 3 [/SUP], Feifei Liu[SUP] 1 [/SUP], Can Li[SUP] 1 [/SUP], Yanxia Chen[SUP] 1 [/SUP], Hin Chu[SUP] 1 [/SUP], Siu-Ying Lau[SUP] 1 [/SUP], Pui Wang[SUP] 1 [/SUP], Chris Chung-Sing Chan[SUP] 1 [/SUP], Vincent Kwok-Man Poon[SUP] 1 [/SUP], Shuofeng Yuan[SUP] 1 [/SUP], Kelvin Kai-Wang To[SUP] 1 2 3 [/SUP], Honglin Chen[SUP] 1 [/SUP], Kwok-Yung Yuen[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

Background: Clinical outcomes of the interaction between the co-circulating pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are unknown.
Methods: We established a golden Syrian hamster model co-infected by SARS-CoV-2 and mouse-adapted A(H1N1)pdm09 simultaneously or sequentially. The weight loss, clinical scores, histopathological changes, viral load and titer, and serum neutralizing antibody titre were compared with hamsters challenged by either virus.
Results: Co-infected hamsters had more weight loss, more severe lung inflammatory damage and tissue cytokine/chemokine expression. Lung viral load, infectious virus titers and virus antigen expression suggested that hamsters were generally more susceptible to SARS-CoV-2 than A(H1N1)pdm09. Sequential co-infection with A(H1N1)pdm09 one day prior to SARS-CoV-2 exposure resulted in a lower lung SARS-CoV-2 titer and viral load than with SARS-CoV-2 infection alone, but a higher lung A(H1N1)pdm09 viral load. Co-infection also increased intestinal inflammation with more SARS-CoV-2 nucleoprotein expression in enterocytes. Simultaneous co-infection was associated with delay in resolution of lung damages, lower serum SARS-CoV-2 neutralizing antibody and longer SARS-CoV-2 shedding in oral swabs compared to that of SARS-CoV-2 infection alone.
Conclusions: Simultaneous or sequential co-infection by SARS-CoV-2 and A(H1N1)pdm09 caused more severe disease than infection by either virus in hamsters. Prior A(H1N1)pdm09 infection lowered SARS-CoV-2 pulmonary viral loads but enhanced lung damage. Whole-population influenza vaccination for prevention of co-infection, and multiplex molecular diagnostics for both viruses to achieve early initiation of antiviral treatment for improvement of clinical outcome should be considered.

Keywords: COVID-19; SARS-CoV-2; co-infection; coronavirus; influenza.
 
Back
Top Bottom